Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design
The Next Web reports that Isomorphic Labs, the Alphabet drug discovery company run by Demis Hassabis, has raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital, announced on Tuesday, six months after it raised $2.1bn in May. Andreessen Horowitz and several other new investors joined the round. According to the outlet, Hassabis said the company has "very secure compute pipelines" as turmoil at Nvidia worries some AI companies.
Based on The Next Web's report - only one outlet has covered this so far. Read the original.Coverage 1 source · 1 report
Chronological.
-
Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design
Isomorphic Labs, the Alphabet drug discovery company run by Demis Hassabis, has raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital. The company announced the round on Tuesday, six months after it raised $2.1bn in May. Andreessen Horowitz and several other new investors joined, with what Isomorphic called continued significant investment […] This story continues at The Next Web
Discussion 0 comments